Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Frizzled 9 ELISA Kit (AC3325)
Cat.#: ASET-1914
Specifications
Description Human Frizzled 9 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Frizzled 9 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.87 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1298 Guinea Pig Insulin ELISA Kit (AC2709) Quantitative inquiry ASET-2057 Monkey Adiponectin ELISA Kit (AC3468) Quantitative inquiry ASET-2388 Rabbit CRH ELISA Kit (AC3799) Quantitative inquiry ASET-1775 Mouse ProDynorphin ELISA Kit (AC3186) Quantitative inquiry ASET-1165 Mouse HDL ELISA Kit (AC2576) Quantitative inquiry ASET-1041 Mouse CORT ELISA Kit (AC2452) Quantitative inquiry ASET-1471 Mouse GSK3 beta ELISA Kit (AC2882) Quantitative inquiry ASET-1898 Monkey beta Nerve Growth Factor ELISA Kit (AC3309) Quantitative inquiry ASET-2402 Horse IL-6 ELISA Kit (AC3813) Quantitative inquiry ASET-1568 Human GPCR GPR35 ELISA Kit (AC2979) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket